37 reports

  • Asthma
  • Hiatal hernia

About GERD Drugs Gastroesophageal reflux disease (GERD) is a chronic digestive disorder that affects the lower esophageal sphincter (LES), the ring of muscle between the stomach and esophagus. It occurs when acidic stomach juices, or food and fluids flow back up into the food pipe (esophagus). The backwash irritates the lining of the...

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited

The auto exports exceeded over ## million each year.

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca PLC
  • Xian-Janssen Pharmaceutical Ltd.
  • 4.1 BIBLIOGRAPHY

Annals of Allergy, Asthma and Immunology; ##(##): ##-##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Italy
  • Forecast

Other co-morbidities associated with GERD are asthma, gall bladder disease, otitis, sinusitis, anxiety and depression (Hungin et al., 2005).

  • Gastrointestinal Drug
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

The auto exports exceeded over ## million each year.

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.

There are many small producers whose capacity is below one billion Yuan.

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca PLC
  • Xian-Janssen Pharmaceutical Ltd.

The company mainly sells drugs treating HBV, asthmas and infections.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.
  • 12.1 BIBLIOGRAPHY

ANNALS OF ALLERGY, ASTHMA AND IMMUNOLOGY; ##(##): ##- ##.

  • Gastrointestinal Drug
  • Allergan plc
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Ironwood Pharmaceuticals, Inc.

The treatment aims to eliminate the symptoms such as heartburn, acidic taste in mouth, hoarseness, dry cough, asthma etc & cure the disease.

  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • World

There are many small producers whose capacity is below one billion yuan.

  • Gastrointestinal Drug
  • China
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.
  • Nanjing Aosaikang Medicinal Group
  • 5.7.2. PRODUCT PORTFOLIO

ACTIVE INDUSTRY PLAYERS FIGURE ##. ## MICROBIOME THERAPEUTICS: ACTIVE INDUSTRY PLAYERS ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Phase I Phase I (planned) Preclinical Discovery Phase (Unknown) ## ##.

  • Gastrointestinal Drug
  • North America
  • United States
  • Market Size
  • MicroBiome Therapeutics LLC

A large number of people suffer from respiratory problems such as hay fever and asthma, and the poor air quality worsens their health PROSPECTS Passport ## conditions.

  • Gastrointestinal Drug
  • OTC
  • Vitamin
  • China
  • Demand

Drivers and their Impact Impact on key customer category disease Increase in patient population Regulatory and distribution channel Non-complex etiology Growing geriatric population framework Low Low ## ## ## ## ## High High ## ## ## ## ## ## ## ## ## ## Low High ## ## ## ## ##

  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.

Approximately one in five adults reaches the minimum recommendation of The Norwegian Directorate of Health, meaning one in five adults does at least ## minutes of physical activity per day on average.

  • Gastrointestinal Drug
  • OTC
  • Norway
  • Demand

The company mainly sells drugs treating HBV, asthmas and infections.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.
  • Introduction
  • JANSSEN GLOBAL SERVICES, LLC, 2015*

Subjects were randomized in the ratio ##:## to one of the two arms.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

Pain; ##: ##-##.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.
  • Salix Pharmaceuticals, Ltd.
  • CLINICAL TRIAL OVERVIEW OF TOP COMPANIES
  • ESOPHAGEAL DISEASES THERAPEUTICS CLINICAL TRIALS MARKET, GLOBAL, CLINICAL TRIALS BY TAKEDA PHARMACEUTICAL COMPANY

The prominent features of this report are - ##.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • CLINICAL TRIAL OVERVIEW OF TOP COMPANIES
  • ESOPHAGITIS THERAPEUTICS CLINICAL TRIALS MARKET, GLOBAL, CLINICAL TRIALS BY TAKEDA PHARMACEUTICAL COMPANY LIMITED,

The prominent features of this report are - ##.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

The panel expressed concerns over side-effects and the possibility for off-label use for use in asthma patients.

  • Gastrointestinal Drug
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

In the Phase IIb study, subjects with uncontrolled severe asthma and elevated baseline blood eosinophil levels taking benralizumab had a statistically significant reduction in their asthma exacerbation rate (AER), as well as improvements in lung function (FEV##) and asthma

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Product Initiative
  • RedHill Biopharma Ltd.

The prominent features of this report are - ##.

  • Drug Discovery And Development
  • Gastrointestinal Drug
  • United States
  • World
  • Salix Pharmaceuticals, Ltd.

Patent and Trademark Office for a pending patent application, which covers the use of MN-## for the treatment of acute exacerbations of asthma.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Target
  • Clinical Trial profile. 895 Trial Title

Asthma Anti-Interleukin-## (IL##) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma GDCT## NCT##, RES-## Gastrointestinal Asthma, Eosinophilic Esophagitis (CD##, Hematopoietic Progenitor Cell Antigen CD## (CD##), T Cell Surface Glycoprotein C

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World

The company' s products include penthrox, asthma and COPD, medical devices and veterinary products.

  • Gastrointestinal Drug
  • Healthcare
  • Pharmaceutical
  • United States
  • Purdue Pharma L.P.
  • Mar 14, 2018: Ardelyx Reports 2017 Financial Results

Lundberg was also the co-founder of Aerocrine AB, a biotech diagnostic company with exhaled nitric oxide as an allergic asthma breath test.

  • Gastrointestinal Drug
  • Therapy
  • United States
  • Company Operations
  • Ardelyx, Inc.
  • LICENSING AGREEMENTS
  • PARTNERSHIPS

It is also developing new approaches to the treatment of asthma.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Company Financials
  • Ironwood Pharmaceuticals, Inc.

Its target treatment areas comprise endobronchial cancer, esophageal cancer, high grade dysplasia in Barrett' s esophagus, asthma and head lice infestation among others.

  • Biopharmaceutical
  • Gastrointestinal Drug
  • United States
  • Company Financials
  • RedHill Biopharma Ltd.

The company' s proprietary platform technology is applied in various therapeutic areas such as cancer, pain, asthma, inflammation, sepsis and others.

  • Gastrointestinal Drug
  • Neurological Disorder
  • United States
  • Company
  • Product Initiative

Aslan' s ASLAN## is a small molecule inhibitor of dihydroorotate dehydrogenase inhibitor to treat tumors; and ASLAN## is a full human monoclonal antibody that reduces exacerbation in moderate or severe asthma and improves the functioning of lungs.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • United States
  • Product Initiative